APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cell Therapy

Cell therapy (also called cellular therapy, cell transplantation, or cytotherapy) is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Cell therapy (also called cellular therapy, cell transplantation, or cytotherapy) is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.

Selected research

Market Outlook & Growth Opportunities

Global Cell Therapy Market Outlook and Growth Opportunities 2026

Report ID 173976310431 December 2025191 pages

Choose your research edition.

Industry ResearchCell Therapy Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Cell Therapy Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Cell Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cell Therapy Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Cell Therapy Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Cell therapy (also called cellular therapy, cell transplantation, or cytotherapy) is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.

The classification of Cell Therapy includes Stem Cell therapy and Non-Stem Cell therapy, and the revenue proportion of Stem Cell therapy in 2019 is about 98.76%.

Cell Therapy is widely used in Hospital, Clinics and Other. The most proportion of Cell Therapy is Hospital, and the proportion in 2019 is about 77.2%.

Read the full market overview

North Americas is the largest consumption place, with a consumption market share nearly 43.65% in 2019. Following North Americas, Europe is the second largest consumption place with the consumption market share of 35.41%.

This report provides an overview of the global Cell Therapy market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cell Therapy and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cell Therapy revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Cell Therapy market.

Cell Therapy Segment by Company

Gilead Sciences

Novartis

Osiris

Vericel Corporation

Vcanbio

Fujifilm Cellular Dynamics

JCR Pharmaceuticals

Beike Biotechnology

Golden Meditech

Guanhao Biotech

Cell Therapy Segment by Type

Stem Cell

Non-Stem Cell

Cell Therapy Segment by Application

Hospital

Clinic

Cell Therapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Cell Therapy status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Cell Therapy key companies, revenue, market share, and recent developments.

3. To split the Cell Therapy breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Cell Therapy market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cell Therapy significant trends, drivers, influence factors in global and regions.

6. To analyze Cell Therapy competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cell Therapy industry.

Chapter 3: Detailed analysis of Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Cell Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Cell Therapy in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cell Therapy Industry Trends Table 2. Cell Therapy Industry Drivers Table 3. Cell Therapy Industry Opportunities and Challenges Table 4. Cell Therapy Industry Restraints Table 5. Global Cell Therapy Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cell Therapy Revenue Share by Company (2021-2026) Table 7. Global Cell Therapy Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Cell Therapy Key Company Manufacturing Base & Headquarters Table 9. Global Cell Therapy Company, Product Type & Application Table 10. Global Cell Therapy Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Stem Cell Table 15. Significant Companies of Non-Stem Cell Table 16. Global Cell Therapy Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Cell Therapy Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Cell Therapy Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Cell Therapy Sales Value Share by Type (2021-2026) Table 20. Global Cell Therapy Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Clinic Table 23. Global Cell Therapy Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Cell Therapy Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Cell Therapy Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Cell Therapy Sales Value Share by Application (2021-2026) Table 27. Global Cell Therapy Sales Value Share by Application (2027-2032) Table 28. Global Cell Therapy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Cell Therapy Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Cell Therapy Sales Value Share by Region (2021-2026) Table 31. Global Cell Therapy Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Cell Therapy Sales Value Share by Region (2027-2032) Table 33. Global Cell Therapy Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Cell Therapy Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Cell Therapy Sales Value Market Share by Country (2021-2026) Table 36. Global Cell Therapy Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Cell Therapy Sales Value Market Share by Country (2027-2032) Table 38. Gilead Sciences Company Information Table 39. Gilead Sciences Business Overview Table 40. Gilead Sciences Cell Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Gilead Sciences Cell Therapy Product Portfolio Table 42. Gilead Sciences Recent Development Table 43. Novartis Company Information Table 44. Novartis Business Overview Table 45. Novartis Cell Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Novartis Cell Therapy Product Portfolio Table 47. Novartis Recent Development Table 48. Osiris Company Information Table 49. Osiris Business Overview Table 50. Osiris Cell Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Osiris Cell Therapy Product Portfolio Table 52. Osiris Recent Development Table 53. Vericel Corporation Company Information Table 54. Vericel Corporation Business Overview Table 55. Vericel Corporation Cell Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Vericel Corporation Cell Therapy Product Portfolio Table 57. Vericel Corporation Recent Development Table 58. Vcanbio Company Information Table 59. Vcanbio Business Overview Table 60. Vcanbio Cell Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Vcanbio Cell Therapy Product Portfolio Table 62. Vcanbio Recent Development Table 63. Fujifilm Cellular Dynamics Company Information Table 64. Fujifilm Cellular Dynamics Business Overview Table 65. Fujifilm Cellular Dynamics Cell Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Fujifilm Cellular Dynamics Cell Therapy Product Portfolio Table 67. Fujifilm Cellular Dynamics Recent Development Table 68. JCR Pharmaceuticals Company Information Table 69. JCR Pharmaceuticals Business Overview Table 70. JCR Pharmaceuticals Cell Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. JCR Pharmaceuticals Cell Therapy Product Portfolio Table 72. JCR Pharmaceuticals Recent Development Table 73. Beike Biotechnology Company Information Table 74. Beike Biotechnology Business Overview Table 75. Beike Biotechnology Cell Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Beike Biotechnology Cell Therapy Product Portfolio Table 77. Beike Biotechnology Recent Development Table 78. Golden Meditech Company Information Table 79. Golden Meditech Business Overview Table 80. Golden Meditech Cell Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Golden Meditech Cell Therapy Product Portfolio Table 82. Golden Meditech Recent Development Table 83. Guanhao Biotech Company Information Table 84. Guanhao Biotech Business Overview Table 85. Guanhao Biotech Cell Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Guanhao Biotech Cell Therapy Product Portfolio Table 87. Guanhao Biotech Recent Development Table 88. Research Programs/Design for This Report Table 89. Authors List of This Report Table 90. Secondary Sources Table 91. Primary Sources List of Figures Figure 1. Cell Therapy Product Image Figure 2. Global Cell Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 4. Global Cell Therapy Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Stem Cell Image Figure 8. Non-Stem Cell Image Figure 9. Global Cell Therapy Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Cell Therapy Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Cell Therapy Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Clinic Image Figure 14. Global Cell Therapy Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Cell Therapy Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Cell Therapy Sales Value Share by Application (2021-2032) Figure 17. Global Cell Therapy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Cell Therapy Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Cell Therapy Sales Value (2021-2032) & (US$ Million) Figure 20. North America Cell Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Cell Therapy Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Cell Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Cell Therapy Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Cell Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Cell Therapy Sales Value (2021-2032) & (US$ Million) Figure 26. South America Cell Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Cell Therapy Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Cell Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Stem Cell
  • Non-Stem Cell
Applications
  • Hospital
  • Clinic
Companies covered
  • Gilead Sciences
  • Novartis
  • Osiris
  • Vericel Corporation
  • Vcanbio
  • Fujifilm Cellular Dynamics
  • JCR Pharmaceuticals
  • Beike Biotechnology
  • Golden Meditech
  • Guanhao Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cell Therapy Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cell Therapy Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Cell Therapy Market Dynamics
  1. 2.1 Cell Therapy Industry Trends
  2. 2.2 Cell Therapy Industry Drivers
  3. 2.3 Cell Therapy Industry Opportunities and Challenges
  4. 2.4 Cell Therapy Industry Restraints
3 Cell Therapy Market by Company
  1. 3.1 Global Cell Therapy Company Revenue Ranking in 2025
  2. 3.2 Global Cell Therapy Revenue by Company (2021-2026)
  3. 3.3 Global Cell Therapy Company Ranking (2024-2026)
  4. 3.4 Global Cell Therapy Company Manufacturing Base and Headquarters
  5. 3.5 Global Cell Therapy Company Product Type and Application
  6. 3.6 Global Cell Therapy Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Cell Therapy Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Cell Therapy Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Cell Therapy Market by Type
  1. 4.1 Cell Therapy Type Introduction
  2. 4.1.1 Stem Cell
  3. 4.1.2 Non-Stem Cell
  4. 4.2 Global Cell Therapy Sales Value by Type
  5. 4.2.1 Global Cell Therapy Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Cell Therapy Sales Value by Type (2021-2032)
  7. 4.2.3 Global Cell Therapy Sales Value Share by Type (2021-2032)
5 Cell Therapy Market by Application
  1. 5.1 Cell Therapy Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Cell Therapy Sales Value by Application
  5. 5.2.1 Global Cell Therapy Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Cell Therapy Sales Value by Application (2021-2032)
  7. 5.2.3 Global Cell Therapy Sales Value Share by Application (2021-2032)
6 Cell Therapy Regional Value Analysis
  1. 6.1 Global Cell Therapy Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cell Therapy Sales Value by Region (2021-2032)
  3. 6.2.1 Global Cell Therapy Sales Value by Region: 2021-2026
  4. 6.2.2 Global Cell Therapy Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cell Therapy Sales Value (2021-2032)
  7. 6.3.2 North America Cell Therapy Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Cell Therapy Sales Value (2021-2032)
  10. 6.4.2 Europe Cell Therapy Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Cell Therapy Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Cell Therapy Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Cell Therapy Sales Value (2021-2032)
  16. 6.6.2 South America Cell Therapy Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Cell Therapy Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Cell Therapy Sales Value Share by Country, 2025 VS 2032
7 Cell Therapy Country-level Value Analysis
  1. 7.1 Global Cell Therapy Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cell Therapy Sales Value by Country (2021-2032)
  3. 7.2.1 Global Cell Therapy Sales Value by Country (2021-2026)
  4. 7.2.2 Global Cell Therapy Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Cell Therapy Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Cell Therapy Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Cell Therapy Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Cell Therapy Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Cell Therapy Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Cell Therapy Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Cell Therapy Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Cell Therapy Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Cell Therapy Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Cell Therapy Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Cell Therapy Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Cell Therapy Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Cell Therapy Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Cell Therapy Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Cell Therapy Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Cell Therapy Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Cell Therapy Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Cell Therapy Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Cell Therapy Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Cell Therapy Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Cell Therapy Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Cell Therapy Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Cell Therapy Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Cell Therapy Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Cell Therapy Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Cell Therapy Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Cell Therapy Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Cell Therapy Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Cell Therapy Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Cell Therapy Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Cell Therapy Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Cell Therapy Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Cell Therapy Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Cell Therapy Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Cell Therapy Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Cell Therapy Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Cell Therapy Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Cell Therapy Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Cell Therapy Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Cell Therapy Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Cell Therapy Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Cell Therapy Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Cell Therapy Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Cell Therapy Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Cell Therapy Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Cell Therapy Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Cell Therapy Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Cell Therapy Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Cell Therapy Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Cell Therapy Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Cell Therapy Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Cell Therapy Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Cell Therapy Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Cell Therapy Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Cell Therapy Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Cell Therapy Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Cell Therapy Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Cell Therapy Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Cell Therapy Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Cell Therapy Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Cell Therapy Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Cell Therapy Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Cell Therapy Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Cell Therapy Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Cell Therapy Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Cell Therapy Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Cell Therapy Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Cell Therapy Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Cell Therapy Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Cell Therapy Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Cell Therapy Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Cell Therapy Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Cell Therapy Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Cell Therapy Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Cell Therapy Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Cell Therapy Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Cell Therapy Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Cell Therapy Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Cell Therapy Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Cell Therapy Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Cell Therapy Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Cell Therapy Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Cell Therapy Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Cell Therapy Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Gilead Sciences
  2. 8.1.1 Gilead Sciences Company Information
  3. 8.1.2 Gilead Sciences Business Overview
  4. 8.1.3 Gilead Sciences Cell Therapy Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Gilead Sciences Cell Therapy Product Portfolio
  6. 8.1.5 Gilead Sciences Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Cell Therapy Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Cell Therapy Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Osiris
  14. 8.3.1 Osiris Company Information
  15. 8.3.2 Osiris Business Overview
  16. 8.3.3 Osiris Cell Therapy Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Osiris Cell Therapy Product Portfolio
  18. 8.3.5 Osiris Recent Developments
  19. 8.4 Vericel Corporation
  20. 8.4.1 Vericel Corporation Company Information
  21. 8.4.2 Vericel Corporation Business Overview
  22. 8.4.3 Vericel Corporation Cell Therapy Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Vericel Corporation Cell Therapy Product Portfolio
  24. 8.4.5 Vericel Corporation Recent Developments
  25. 8.5 Vcanbio
  26. 8.5.1 Vcanbio Company Information
  27. 8.5.2 Vcanbio Business Overview
  28. 8.5.3 Vcanbio Cell Therapy Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Vcanbio Cell Therapy Product Portfolio
  30. 8.5.5 Vcanbio Recent Developments
  31. 8.6 Fujifilm Cellular Dynamics
  32. 8.6.1 Fujifilm Cellular Dynamics Company Information
  33. 8.6.2 Fujifilm Cellular Dynamics Business Overview
  34. 8.6.3 Fujifilm Cellular Dynamics Cell Therapy Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Fujifilm Cellular Dynamics Cell Therapy Product Portfolio
  36. 8.6.5 Fujifilm Cellular Dynamics Recent Developments
  37. 8.7 JCR Pharmaceuticals
  38. 8.7.1 JCR Pharmaceuticals Company Information
  39. 8.7.2 JCR Pharmaceuticals Business Overview
  40. 8.7.3 JCR Pharmaceuticals Cell Therapy Revenue and Gross Margin (2021-2026)
  41. 8.7.4 JCR Pharmaceuticals Cell Therapy Product Portfolio
  42. 8.7.5 JCR Pharmaceuticals Recent Developments
  43. 8.8 Beike Biotechnology
  44. 8.8.1 Beike Biotechnology Company Information
  45. 8.8.2 Beike Biotechnology Business Overview
  46. 8.8.3 Beike Biotechnology Cell Therapy Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Beike Biotechnology Cell Therapy Product Portfolio
  48. 8.8.5 Beike Biotechnology Recent Developments
  49. 8.9 Golden Meditech
  50. 8.9.1 Golden Meditech Company Information
  51. 8.9.2 Golden Meditech Business Overview
  52. 8.9.3 Golden Meditech Cell Therapy Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Golden Meditech Cell Therapy Product Portfolio
  54. 8.9.5 Golden Meditech Recent Developments
  55. 8.10 Guanhao Biotech
  56. 8.10.1 Guanhao Biotech Company Information
  57. 8.10.2 Guanhao Biotech Business Overview
  58. 8.10.3 Guanhao Biotech Cell Therapy Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Guanhao Biotech Cell Therapy Product Portfolio
  60. 8.10.5 Guanhao Biotech Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst